Last reviewed · How we verify
Iron and Folic Acid
At a glance
| Generic name | Iron and Folic Acid |
|---|---|
| Sponsor | Indian Council of Medical Research |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Patient Blood Management in Cardiac Surgery (NA)
- EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA (NA)
- Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy (NA)
- Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial (PHASE3)
- Effectiveness and Acceptability of Weekly Iron Folic Acid Supplementation With Conditional Cash Transfer (WIFASCCT) Among Adolescent Girls in Four Districts of Pakistan in Low Income Setting (NA)
- Improving Uptake of Antenatal Care Services in Rural Côte d'Ivoire (NA)
- Chemo Brain Prehab Project (NA)
- BEP Targeting Strategies in Ethiopia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Iron and Folic Acid CI brief — competitive landscape report
- Iron and Folic Acid updates RSS · CI watch RSS
- Indian Council of Medical Research portfolio CI